CTMX vs BIIB: Which Stock is Better?
Side-by-side comparison of CytomX Therapeutics Inc and Biogen Inc in 2026
CTMX
CytomX Therapeutics Inc
$5.37
BIIB
Biogen Inc
$165.38
Key Metrics Comparison
| Metric | CTMX | BIIB | Winner |
|---|---|---|---|
| Market Cap | $913.26M | $24.26B | BIIB |
| P/E Ratio | 17.97 | 15.09 | BIIB |
| EPS (TTM) | $0.30 | $10.96 | BIIB |
| Revenue Growth | -0.8% | 0.0% | BIIB |
| Gross Margin | 100.0% | 76.6% | CTMX |
Analyze CTMX
Full quant analysis
Analyze BIIB
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is CTMX or BIIB a better investment?
Comparing CTMX and BIIB: CytomX Therapeutics Inc has a market cap of $913.26M while Biogen Inc has $24.26B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between CTMX and BIIB?
CTMX (CytomX Therapeutics Inc) and BIIB (Biogen Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: CTMX or BIIB?
Based on P/E ratios, BIIB trades at a lower multiple (15.1x vs 18.0x).
Which is growing faster: CTMX or BIIB?
BIIB has higher revenue growth at 0.0% vs -0.8% for CTMX.
Which company is more profitable: CTMX or BIIB?
CytomX Therapeutics Inc (CTMX) has higher gross margins at 100.0% compared to 76.6% for BIIB.
Which is the larger company: CTMX or BIIB?
Biogen Inc (BIIB) is larger with a market cap of $24.26B compared to $913.26M for CTMX.
Should I buy CTMX or BIIB in 2026?
Both CTMX and BIIB have investment merit. CTMX trades at $5.37 while BIIB trades at $165.38. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between CTMX and BIIB stock?
Key differences: Market Cap ($913.26M vs $24.26B), P/E Ratio (18.0x vs 15.1x), Revenue Growth (-0.8% vs 0.0%), Gross Margin (100.0% vs 76.6%).